The Effect of a Neutropenic Diet on Infection and Mortality Rates in Cancer Patients: A Meta-Analysis

REFERENCES

• Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, et al.: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52, e56–e93, 2011. doi:10.1093/cid/cir073
   PubMed Web of Science ®Google Scholar
• Fox N and Freifeld AG: The neutropenic diet reviewed: moving toward a safe food handling approach. Oncology (Williston Park) 26, 572–5, 580, 582 passim, 2012.
   PubMed Web of Science ®Google Scholar
• Poe SS, Larson E, McGuire D, and Krumm S: A national survey of infection prevention practices on bone marrow transplant units. Oncol Nurs Forum 21, 1687–1694, 1994.
   PubMedGoogle Scholar
• Smith LH and Besser SG: Dietary restrictions for patients with neutropenia: a survey of institutional practices. Oncol Nurs Forum 27, 515–520, 2000.
   PubMedGoogle Scholar
• Braun LE, Chen H, and Frangoul H: Significant inconsistency among pediatric oncologists in the use of the neutropenic diet. Pediatr Blood Cancer 61, 1806–1810, 2014. doi:10.1002/pbc.25104
   PubMed Web of Science ®Google Scholar
• Carr SE and Halliday V: Investigating the use of the neutropenic diet: a survey of UK dietitians. J Hum Nutr Diet 339, 2014. doi: 10.1111/jhn.12266
   Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62, e1–e34, 2009. doi: S0895-4356(09)00180-2 [pii]
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, et al.: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343, d5928, 2011. doi:10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• Wells GA SB, O'Connell D, Paterson J, Welch V, Losos M, et al.: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• DerSimonian R and Kacker R: Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28, 105–114, 2007. doi:10.1016/j.cct.2006.04.004
   PubMed Web of Science ®Google Scholar
• Higgins JPT and Green S (eds.).: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org
   Google Scholar
• Gardner A, Mattiuzzi G, Faderl S, Borthakur G, Garcia-Manero G, et al.: Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol 26, 5684–5688, 2008. doi:10.1200/JCO.2008.16.4681
   PubMed Web of Science ®Google Scholar
• Moody K, Finlay J, Mancuso C, and Charlson M: Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines. J Pediatr Hematol Oncol 28, 126–133, 2006. doi:10.1097/01.mph.0000210412.33630.fb
   PubMed Web of Science ®Google Scholar
• Trifilio S, Helenowski I, Giel M, Gobel B, Pi J, et al.: Questioning the role of a neutropenic diet following hematopoetic stem cell transplantation. Biol Blood Marrow Transplant 18, 1385–1390, 2012. doi:10.1016/j.bbmt.2012.02.015
   PubMed Web of Science ®Google Scholar
• van Tiel F, Harbers MM, Terporten PH, van Boxtel RT, Kessels AG, et al.: Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety. Ann Oncol 18, 1080–1084, 2007. doi:10.1093/annonc/mdm082
   PubMed Web of Science ®Google Scholar
• van Dalen EC, Mank A, Leclercq E, Mulder RL, Davies M, et al.: Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. Cochrane Database Syst Rev 9, CD006247, 2012. doi:10.1002/14651858.CD006247.pub2
   Web of Science ®Google Scholar
• Mank AP and Davies M: Examining low bacterial dietary practice: a survey on low bacterial food. Eur J Oncol Nurs 12, 342–348, 2008. doi:10.1016/j.ejon.2008.03.005
   PubMed Web of Science ®Google Scholar
• Bozzetti F: Nutritional support of the oncology patient. Crit Rev Oncol Hematol 87, 172–200, 2013. doi:10.1016/j.critrevonc.2013.03.006
   PubMed Web of Science ®Google Scholar
• Deitch EA: Bacterial translocation: the influence of dietary variables. Gut 35, S23–S27, 1994.
   PubMed Web of Science ®Google Scholar
• Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, et al.: The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124, 1174–1182, 2014. doi:10.1182/blood-2014-02-554725
   PubMed Web of Science ®Google Scholar
• Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, et al.: Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307, 1959–1969, 2012. doi:10.1001/jama.2012.3507
   PubMed Web of Science ®Google Scholar
• Gill HS, Rutherfurd KJ, Cross ML, and Gopal PK: Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74, 833–839, 2001.
   PubMed Web of Science ®Google Scholar
• Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, et al.: Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343, 69–76, 2006. doi:10.1016/j.bbrc.2006.02.080
   PubMed Web of Science ®Google Scholar
• Amiri-Kordestani L, Wedam S, Zhang L, Tang S, Tilley A, et al.: First FDA approval of neoadjuvant therapy for breast cancer: Pertuzumab for the treatment of patients with HER2-positive breast cancer. Clinical Cancer Research 20, 5359–5364, 2014. doi:10.1158/1078-0432.ccr-14-1268
   PubMed Web of Science ®Google Scholar
• Lan JG, Cruickshank SM, Singh JC, Farrar M, Lodge JP, et al.: Different cytokine response of primary colonic epithelial cells to commensal bacteria. World J Gastroenterol 11, 3375–3384, 2005.
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241, 2004. doi:10.1016/j.cell.2004.07.002
   PubMed Web of Science ®Google Scholar
• Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126, 1620–1633, 2004.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick LR: Probiotics for the treatment of Clostridium difficile associated disease. World J Gastrointest Pathophysiol 4, 47–52, 2013. doi:10.4291/wjgp.v4.i3.47
   PubMedGoogle Scholar
• Hamada N, Tajima F, Sakuno M, Tanabe K, Hasegawa R, et al.: The influence of dietary restriction on quality of life in the patients with hematological malignancies who received chemotherapy: a single-institution study. Blood 122, 5586, 2013.
   Web of Science ®Google Scholar